BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 27, 2016
View Archived Issues
Compugen announces new lead candidate
Read More
Kitov Pharmaceuticals reports new data from KIT-302 phase III study
Read More
Novel beta-lactamase inhibitor ETX-2514 demonstrates promising in vitro and in vivo efficacy
Read More
FADDI-287, a new polymyxin B derivative with improved safety and activity
Read More
IMSUT and Astellas sign collaborative development agreement for MucoRice-CTB
Read More
Phase I results support daily subcutaneous dosing of Apellis Pharmaceuticals' APL-2
Read More
Pfizer completes acquisition of Anacor Pharmaceuticals
Read More
Takeda revises Japanese collaboration agreement with Amgen
Read More
Janssen Pharmaceutica patents mGlu2 receptor PAMs
Read More
Merck & Co. discloses HIV integrase inhibitors
Read More
Charles University in Prague describes antituberculosis agents
Read More
New Pharma Licence Holdings develops antibacterial agents
Read More
Sanofi and Boehringer Ingelheim reach definitive agreements on business exchange
Read More
Bayer Schering Pharma presents VEGFR-2 and PDGFR-beta inhibitors
Read More
Genticel reports 18-month data from phase II trial of HPV immunotherapeutic candidate
Read More
VBI Vaccines cleared to begin phase I study of CMV vaccine candidate in Canada
Read More
NIH-supported researchers develop clinical-grade stem cell line
Read More
Cellectar Biosciences' CLR-125 shows activity in TNBC xenografts
Read More
New phosphate prodrug of alvocidib shows efficacy in mice
Read More
EMA's CHMP grants positive opinion to Teva's reslizumab
Read More
Regulatory dossier for Sanofi Pasteur's VaxigripTetra approved in Europe
Read More
Long-acting amylin analogues ZP-4982 and ZP-5461 improve glycemic control in diabetes model
Read More
Gilead Sciences' Odefsey approved in Europe
Read More
Cosmo Pharmaceuticals obtains rights to PAION's remimazolam
Read More
